Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
K. Navari, N. Ziaee (Bandar Abbas, Islamic Republic Of Iran). Iodopovodine is the choice drug for any kind of pleural effusion in developing countries. Eur Respir J 2010; 36: Suppl. 54, 709

Member's Comments

No comment yet.

Related content which might interest you: Malignant pleural effusion: different treatments through countries Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction Year: 2021 Is the size of pleural effusion important in the study of patients whose first tumor manifestation is a pleural effusion? Source: International Congress 2017 – Pleural and mediastinal malignancies Year: 2017 The incidence and dynamics of pleural effusion during TB epidemic on Ukraine Source: Eur Respir J 2004; 24: Suppl. 48, 363s Year: 2004 What is the optimal indication of thoracoscopy for pleural effusion in children? Source: Eur Respir J 2003; 22: Suppl. 45, 319s Year: 2003 An interesting case of undiagnosed pleural effusion Source: Breathe, 13 (2) e46; 10.1183/20734735.001117 Year: 2017 A comparative study of tubercular pleural effusion and parapneumonic pleural effusion in non-HIV patients from a tuberculosis endemic area of Asia Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA) Year: 2016 In search of an ideal method to diagnose tuberculous pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 612s Year: 2006 The new method for diagnosis of pleural effusion of unknown etiology Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis I Year: 2008 Pleural effusion: TB and not TB Source: Annual Congress 2006 - MP12 - Pleural effusion: TB and not TB Year: 2006 Adenosine deaminase (ADA) in diagnosis of tuberculous pleural effusions in a developing country and region with average incidence of pulmonary tuberculosis Source: Annual Congress 2007 - Immunology and genetics of tuberculosis Year: 2007 The effect of a pleural diseases clinic on pleural effusion admission rates Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions Year: 2012 ERS/EACTS statement on the management of malignant pleural effusions Source: Eur Respir J, 52 (1) 1800349; 10.1183/13993003.00349-2018 Year: 2018 ERS/EACTS statement on the management of malignant pleural effusions Source: Guideline 2018 Year: 2018 Surgical problems with the malignant pleural space Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis Year: 2006 An uncommon therapeutic option for a challenging cause of pleural effusion Source: Breathe, 15 (2) e69; 10.1183/20734735.0014-2019 Year: 2019 Efficacy of diagnostics to pleural effusions of unknown etiology during TB epidemic in Ukraine Source: Eur Respir J 2005; 26: Suppl. 49, 414s Year: 2005 How often is a single therapeutic aspiration sufficient to manage a malignant pleural effusion and does oncological treatment have an impact on this? Source: International Congress 2019 – Pleural disease: applying the evidence Year: 2019 The feasibility of medical thoracoscopy in the treatment of multi-locculated pleural effusion Source: Annual Congress 2012 - Special problems in thoracic surgery Year: 2012 Early effective drainage in the treatment of loculated tuberculous pleurisy Source: Eur Respir J 2008; 31: 1261-1267 Year: 2008